Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

被引：0
|
作者：
J. Hiltunen
P. Parmanne
T. Sokka
T. Lamberg
P. Isomäki
O. Kaipiainen-Seppänen
R. Peltomaa
T. Uutela
L. Pirilä
K. Taimen
M. J. Kauppi
T. Yli-Kerttula
R. Tuompo
H. Relas
S. Kortelainen
K. Paalanen
J. Asikainen
P. Ekman
A. Santisteban
K.-L. Vidqvist
K. Tadesse
M. Romu
J. Borodina
P. Elfving
H. Valleala
M. Leirisalo-Repo
V. Rantalaiho
H. Kautiainen
T. S. Jokiranta
K. K. Eklund
机构：
[1] Helsinki University and Helsinki University Hospital,Department of Rheumatology
[2] Jyväskylä Central Hospital,Department of Rheumatology
[3] University of Eastern Finland,Department of Rheumatology
[4] United Medix Laboratories,Department of Rheumatology
[5] Tampere University Hospital,Department of Rheumatology
[6] Kuopio University Hospital,Department of Rheumatology
[7] Central Hospital of Lapland,Department of Rheumatology
[8] Turku University Hospital,Department of Rheumatology
[9] Päijät-Häme Central Hospital,Translational Immunology Research Program
[10] University of Tampere,Department of Rheumatology
[11] Satakunta Central Hospital,undefined
[12] Medcare Foundation,undefined
[13] SYNLAB Finland,undefined
[14] Helsinki University and Orton Research Foundation,undefined
[15] Orton Hospital,undefined
[16] Mikkeli Central Hospital,undefined
来源：
Rheumatology International | 2022年 / 42卷
关键词：
Spondyloarthritis; Ankylosing spondylitis; Biological therapy; Anti-drug antibodies; Disease activity; Therapeutic drug monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1025
页数：10
相关论文
共 50 条
  • [31] REAL-LIFE PERFORMANCE OF THE ASAS HEALTH INDEX IN ROUTINE CARE OF PATIENTS WITH SPONDYLOARTHRITIS
    Kiltz, U.
    Wiatr, T.
    Baraliakos, X.
    Fedorov, K.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 663 - 663
  • [32] Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results
    Bilge, Nazife Sule Yasar
    Kalyoncu, Umut
    Atagunduz, Pamir
    Dalkilic, Ediz
    Pehlivan, Yavuz
    Kucuksahin, Orhan
    Bes, Cemal
    Akar, Servet
    Cinar, Muhammet
    Emmungil, Hakan
    Ersozlu, Duygu
    Ates, Askin
    Mercan, Ridvan
    Kimyon, Gezmis
    Koca, Suleyman Serdar
    Gonullu, Emel
    Yazisiz, Veli
    Tekgoz, Emre
    Alpay-Kanitez, Nilufer
    Erden, Abdulsamet
    Kiraz, Sedat
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Ilgen, Ufuk
    Karadag, Omer
    Kilic, Levent
    Ertenli, Ihsan
    Kasifoglu, Timucin
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 228 : 58 - 64
  • [33] The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study
    Zhang, Kui
    Zheng, Yan
    Han, Qing
    Liu, Ying
    Wang, Weitao
    Ding, Jin
    Wang, Yan
    Zhang, Bei
    Jia, Junfeng
    Zheng, Minwen
    Zheng, Zhaohui
    Zhu, Ping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
    Benucci, Maurizio
    Li Gobbi, Francesca
    Bandinelli, Francesca
    Damiani, Arianna
    Infantino, Maria
    Grossi, Valentina
    Manfredi, Mariangela
    Parisi, Simone
    Fusaro, Enrico
    Batticciotto, Alberto
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Meacci, Francesca
    IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 419 - 422
  • [35] Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
    Maurizio Benucci
    Francesca Li Gobbi
    Francesca Bandinelli
    Arianna Damiani
    Maria Infantino
    Valentina Grossi
    Mariangela Manfredi
    Simone Parisi
    Enrico Fusaro
    Alberto Batticciotto
    Piercarlo Sarzi-Puttini
    Fabiola Atzeni
    Francesca Meacci
    Immunologic Research, 2017, 65 : 419 - 422
  • [36] Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial
    Zeremski, Vanja
    Koehler, Michael
    Fischer, Thomas
    Schalk, Enrico
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 793 - 799
  • [37] UTILIZATION OF BACLOFEN IN MAINTENANCE OF ALCOHOL ABSTINENCE IN PATIENTS WITH ALCOHOLIC HEPATITIS IN A REAL-LIFE CLINICAL SETTING
    Avanesyan, Armine
    Runyon, Bruce A.
    HEPATOLOGY, 2010, 52 (04) : 1104A - 1104A
  • [38] Clinical Effectiveness of the Cardiovascular Polypill in a Real-Life Setting in Patients with Cardiovascular Risk: The SORS Study
    Castellano, Jose M.
    Verdejo, Juan
    Ocampo, Salvador
    Martinez Rios, Marco
    Gomez-Alvarez, Enrique
    Borrayo, Gabriela
    Ruiz, Emilio
    Ibanez, Borja
    Fuster, Valentin
    Arroyo, Misael
    Colosia, Maria Teresa
    Becerril, Juan E.
    Vazquez, Roberto
    Rodriguez, Elias
    Rodriguez, Alejandro
    Marquez, Rafael
    Gomez, Enrique
    Gonzalez, Juan M.
    Ubiarco, Jose L.
    Barrera, Jose F.
    Vitela, Bertha
    Aranda, Laura A.
    Pena, Victor
    Guerrero, Miguel A.
    Ibarra, Susana
    Cordoba, Maria I.
    Ledesma, Gloria
    Alarcon, Gustavo
    Campos, Jose A.
    Diez, Jose L.
    Elias, Rafael
    Baez, Victor H.
    Cervantes, Mariano D.
    Apresa, Ratil
    Casian, Javier
    Corral, Rafael
    Delgado, David A.
    Padron, Joel E.
    Hernandez, Victor M.
    Rodriguez, Maria A.
    Gonzalez, Enrique
    Garcia, Alejandro
    Gonzalez, Francisco J.
    Gonzalez, Miguel A.
    Alvarez, Nadia
    Rodriguez, Jorge A.
    Martinez, Francisco
    Gaxiola, Jose A.
    Garcia, Luis J.
    Gonzaga, Luis
    ARCHIVES OF MEDICAL RESEARCH, 2019, 50 (01) : 31 - 40
  • [39] Approach to weight management in patients with advanced chronic kidney disease in a real-life clinical setting
    Lockhart Pastor, Paola
    Amin, Amin
    Galvan, Daniel
    Vasquez, Ofelia Negrete
    Almandoz, Jaime P.
    Lingvay, Ildiko
    OBESITY SCIENCE & PRACTICE, 2024, 10 (03):
  • [40] Characteristics and outcome of patients with primary CNS lymphoma in a “real-life” setting compared to a clinical trial
    Vanja Zeremski
    Michael Koehler
    Thomas Fischer
    Enrico Schalk
    Annals of Hematology, 2016, 95 : 793 - 799
12345